<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="../rssStyle.xslt" version="1.0"?>
<rss version="2.0">
  <channel>
    <title>Biocompare Patent News</title>
    <description>Biocompare.com RSS feed</description>
    <link>http://www.biocompare.com/</link>
    <copyright>&amp;copy; 2010 Biocompare.com</copyright>
    <pubDate>Sun, 01 Aug 2010 02:17:32 GMT</pubDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>U.S. Court Of Appeals Rules On Validity Of Lilly's Gemzar Method-Of-Use Patent</title>
      <description>Eli Lilly and Company  today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335680</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 05:34:00 GMT</pubDate>
    </item>
    <item>
      <title>Encision's Technology Recognized As A Means To Eliminate Surgery Burns</title>
      <description>Encision Inc. , a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, recognized as a technology to eliminate visceral burns during monopolar electrical surgery.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335650</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 05:33:00 GMT</pubDate>
    </item>
    <item>
      <title>NOVAVAX Announces Issuance Of Key U.S. Patent For Influenza Virus-Like Particle (VLP) Vaccines</title>
      <description>Novavax, Inc.  announced today the issuance of U.S. Patent No. 7,763,450 for "Functional Influenza Virus-Like Particles (VLPS)".  The patent covers the use of influenza gene sequences for high-yield production of consistent influenza VLP vaccines to protect against current and future seasonal and pandemic strains of influenza viruses.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335411</link>
      <author>Biocompare.com</author>
      <pubDate>Wed, 28 Jul 2010 04:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Abviva Announces Notice Of Canadian Patent For Technology Used In Breast Cancer Diagnostics And Therapeutics</title>
      <description>Abviva, Inc. , a biomedical company engaged in the development and commercialization of breast cancer-related applications of Mammastatin, announced that the Canadian Patent Office issued notice that it will be issuing patent application Number 2.267.095 within 12 weeks.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335246</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 27 Jul 2010 04:48:00 GMT</pubDate>
    </item>
    <item>
      <title>Nycomed's U.S. Patent For Protonix® (pantoprazole) Valid</title>
      <description>Nycomed's Protonix® Patent Found Infringed and not Obvious
    - U.S. District Court for the District of New Jersey has Upheld Jury
      Findings
    - Nycomed Will Continue to Vigorously Pursue its Damage Claims</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334287</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 20 Jul 2010 03:39:00 GMT</pubDate>
    </item>
    <item>
      <title>High Court Rules On Patent Case</title>
      <description>The biotechnology industry is breathing easier now that the Supreme Court has refused to sharply limit the types of inventions that are eligible for patent protection in the U.S.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334240</link>
      <author>Biocompare.com</author>
      <pubDate>Mon, 19 Jul 2010 07:19:00 GMT</pubDate>
    </item>
    <item>
      <title>Gilead Sciences Files Patent Infringement Lawsuit Against Lupin Limited</title>
      <description>Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has filed a lawsuit in U.S. District Court in New Jersey against Lupin Limited for infringement against Gilead's patents for Ranexa(R) (ranolazine extended-release tablets). The lawsuit is based on an Abbreviated New Drug Application filed by Lupin, which seeks approval to manufacture and market a generic version of Ranexa before the expiration of Gilead's Ranexa patents.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=333938</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 15 Jul 2010 07:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Osseon Receives Patent Allowance For Novel Spinal VCF Treatment Devices</title>
      <description>Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, today received a notice of allowance for its spinal vertebral compression fracture (VCF) technology. The company which was started in 2006 has thirteen additional patent applications pending in the United States and throughout the world for related spinal therapies and devices. The lead inventor for this inaugural patent is Dr. Y. King Liu, one of three founders of Osseon.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=333816</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 15 Jul 2010 03:18:00 GMT</pubDate>
    </item>
    <item>
      <title>Carestream Health Files Patent Infringement Suit Against Caliper Life Sciences</title>
      <description>Carestream Health has filed a lawsuit against Caliper Life Sciences (NASDAQ: CALP) alleging infringement of a patent covering multimodal in vivo imaging.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=333724</link>
      <author>Biocompare.com</author>
      <pubDate>Wed, 14 Jul 2010 10:17:00 GMT</pubDate>
    </item>
    <item>
      <title>Amira Announces AM103 And AM803 Patent Grant In The United Kingdom</title>
      <description>Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, "5-Lipoxygenase Activating Protein (FLAP) Inhibitors," which includes coverage of Amira's AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=333679</link>
      <author>Biocompare.com</author>
      <pubDate>Wed, 14 Jul 2010 03:44:00 GMT</pubDate>
    </item>
  </channel>
</rss>